Literature DB >> 17896833

Individualising therapy for older adults with diabetes mellitus.

Danelle Cayea1, Cynthia Boyd, Samuel C Durso.   

Abstract

The goal when treating patients with diabetes mellitus is to achieve the maximum longevity consistent with an optimal quality of life. To achieve this goal, treatment is typically focused on management of hyperglycaemic symptoms and prevention of microvascular and macrovascular complications. While appropriate for most individuals, including many older adults with robust health, this focus is often too limited for older adults facing diminished life expectancy and co-existing medical illness, frailty and disability. Creating a treatment plan that optimises health and function, and reduces the risk for morbidity and mortality, requires individualised therapy that judiciously manages symptoms and multiple competing health risks while remaining consistent with the patient's or his/her caregiver's healthcare preferences. Physicians caring for older adults with diabetes must be adept at recognising conditions commonly associated with diabetes, including the interplay with co-morbid illness, and be able to assess the patient's health status and use this information to recommend a treatment plan that is consistent with the patient's personal goals for care. The majority of older adults with diabetes will benefit from management of cardiovascular risk, including intensive management of hypertension, lipids, use of aspirin (acetylsalicylic acid) and smoking cessation, and screening for common geriatric syndromes. For a significant minority of older adults with life expectancy of >or=10 years, it is reasonable to consider intensive management of hyperglycaemia (glycosylated haemoglobin [HbA1c] target<or=7%). For frail older adults with life expectancy of <or=5 years, strategies for reducing medical burden, improving function and moderate glucose control (HbA1c approximately 8%) is reasonable and sufficient to control hyperglycaemic symptoms.

Entities:  

Mesh:

Year:  2007        PMID: 17896833     DOI: 10.2165/00002512-200724100-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  76 in total

Review 1.  Clinical practice. Preventing falls in elderly persons.

Authors:  Mary E Tinetti
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

2.  Introduction.

Authors: 
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

3.  Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide.

Authors:  A Holstein; A Plaschke; E H Egberts
Journal:  Diabetes Metab Res Rev       Date:  2001 Nov-Dec       Impact factor: 4.876

4.  The synergistic effect of heart disease and diabetes on self-management, symptoms, and health status.

Authors:  Christi Deaton; Laura P Kimble; Emir Veledar; Pamela Hartigan; William E Boden; Robert A O'Rourke; William S Weintraub
Journal:  Heart Lung       Date:  2006 Sep-Oct       Impact factor: 2.210

5.  Individual sulfonylureas and serious hypoglycemia in older people.

Authors:  R I Shorr; W A Ray; J R Daugherty; M R Griffin
Journal:  J Am Geriatr Soc       Date:  1996-07       Impact factor: 5.562

6.  Comparison of acarbose and metformin in patients with Type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study.

Authors:  B Willms; D Ruge
Journal:  Diabet Med       Date:  1999-09       Impact factor: 4.359

Review 7.  Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Russell Harris; Katrina Donahue; Saif S Rathore; Paul Frame; Steven H Woolf; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

8.  The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression.

Authors:  Wayne J Katon; Michael Von Korff; Elizabeth H B Lin; Greg Simon; Evette Ludman; Joan Russo; Paul Ciechanowski; Edward Walker; Terry Bush
Journal:  Arch Gen Psychiatry       Date:  2004-10

9.  A multifactorial intervention to reduce the risk of falling among elderly people living in the community.

Authors:  M E Tinetti; D I Baker; G McAvay; E B Claus; P Garrett; M Gottschalk; M L Koch; K Trainor; R I Horwitz
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

10.  Progression of lower-extremity disability in older women with diabetes: the Women's Health and Aging Study.

Authors:  Stefano Volpato; Luigi Ferrucci; Caroline Blaum; Glenn Ostir; Anne Cappola; Linda P Fried; Renato Fellin; Jack M Guralnik
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

View more
  11 in total

Review 1.  Special considerations with insulin therapy in older adults with diabetes mellitus.

Authors:  Arshag D Mooradian
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Do we need individualised prescribing quality assessment? The case of diabetes treatment.

Authors:  Petra Denig; Flora Haaijer-Ruskamp
Journal:  Int J Clin Pharm       Date:  2011-04

3.  Frailty Attenuates the Impact of Metformin on Reducing Mortality in Older Adults with Type 2 Diabetes.

Authors:  Chen-Pin Wang; Carlos Lorenzo; Sara E Espinoza
Journal:  J Endocrinol Diabetes Obes       Date:  2014

Review 4.  Antidiabetic oral treatment in older people: does frailty matter?

Authors:  Angela Marie Abbatecola; Giuseppe Paolisso; Andrea Corsonello; Silvia Bustacchini; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

Review 5.  Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project: rationale and methodology.

Authors:  Domenico Fusco; Fabrizia Lattanzio; Matteo Tosato; Andrea Corsonello; Antonio Cherubini; Stefano Volpato; Cinzia Maraldi; Carmelinda Ruggiero; Graziano Onder
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

Review 6.  Frailty and safety: the example of diabetes.

Authors:  Angela M Abbatecola; Fabiola Olivieri; Andrea Corsonello; Felice Strollo; Alessia Fumagalli; Fabrizia Lattanzio
Journal:  Drug Saf       Date:  2012-01       Impact factor: 5.606

Review 7.  Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.

Authors:  Joel C Marrs
Journal:  Drugs Aging       Date:  2012-05-01       Impact factor: 3.923

8.  Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus--a cohort study.

Authors:  Jaco Voorham; Flora M Haaijer-Ruskamp; Bruce H R Wolffenbuttel; Dick de Zeeuw; Ronald P Stolk; Petra Denig
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

Review 9.  Optimal therapy of type 2 diabetes: a controversial challenge.

Authors:  Angela Dardano; Giuseppe Penno; Stefano Del Prato; Roberto Miccoli
Journal:  Aging (Albany NY)       Date:  2014-03       Impact factor: 5.682

10.  Effects of glucose and blood pressure control on diabetic kidney disease in old patients with type 2 diabetes.

Authors:  Tzu-En Wu; Yu-Hsin Chen; Harn-Shen Chen
Journal:  Diabetol Metab Syndr       Date:  2014-07-29       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.